Perspectum Closes $36M Financing Round co-led by Blue Venture Fund and HealthQuest Capital
Perspectum® (“Perspectum” or “the Company”) a medical software company that provides non-invasive technology for identifying and monitoring multiple diseases announced today the completion of a $36M financing from new and existing investors. The company’s first diagnostic product (LiverMultiScan®) uses software to extract quantitative data from current MRI scans to aid with the detection of chronic liver disease. Additionally, Perspectum has an imaging-focused Contract Research Organization (CRO) solutions business that supports biopharmaceutical companies developing assets in liver and metabolic diseases. The funding will drive the commercialization of LiverMultiScan® for clinical use, expand the CRO business as well as develop additional products for biliary disease, diabetes and cancer for both clinical and CRO applications. The investment was co-led by the Blue Venture Fund (“BVF”) and HealthQuest Capital, with participation from Oxford Science Innovation, Puhua Capital and the University of Oxford and other existing investors.